Original Research
Accepted on 30 Sep 2024
In silico and pharmacological evaluation of GPR65 as a cancer immunotherapy target regulating T-cell functions
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1483258
Type at least 3 characters
6,366 articles
Articles
Original Research
Accepted on 30 Sep 2024
Prognostic Value of T Regulatory Cells and Immune Checkpoints Expression in Tumor-Draining Lymph Nodes for Oral Squamous Cell Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1455426
Original Research
Accepted on 30 Sep 2024
Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1491857
Review
Accepted on 30 Sep 2024
The Emerging Role of Cancer-associated Fibroblast in Hematological Malignancies: From Their Influence on Tumor Progression and Drug Resistance to Novel Therapeutic Opportunities
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1442727
Review
Published on 30 Sep 2024
Mechanistic studies of tumor-associated macrophage immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1476565
- 165 views
Review
Published on 30 Sep 2024
Advantages of the zebrafish tumor xenograft model: the evaluation of efficacy in cancer therapy and the application to the study of lncRNAs
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1483192
Original Research
Published on 30 Sep 2024
Peripheral NK cell count predicts response and prognosis in breast cancer patients underwent neoadjuvant chemotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1437193
- 161 views
Review
Published on 30 Sep 2024
The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1417201
- 167 views
Review
Published on 30 Sep 2024
Prognostic biomarkers for immunotherapy in esophageal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1420399
- 121 views
Review
Published on 30 Sep 2024
Finding potential targets in cell-based immunotherapy for handling the challenges of acute myeloid leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1460437
- 228 views
Review
Published on 30 Sep 2024
Make it STING: nanotechnological approaches for activating cGAS/STING as an immunomodulatory node in osteosarcoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1403538
- 239 views
Original Research
Published on 30 Sep 2024
IGFBP7+ subpopulation and IGFBP7 risk score in astrocytoma: insights from scRNA-Seq and bulk RNA-Seq
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1434300
- 103 views
Review
Accepted on 27 Sep 2024
Companion Diagnostics and Predictive Biomarkers for PD-1/PD-L1 Immune Checkpoint Inhibitors Therapy in Malignant Melanoma 1
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1454720
- 176 views
Mini Review
Accepted on 27 Sep 2024
Mitochondrial Regulation in the Tumor Microenvironment: Targeting Mitochondria for Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1453886
Original Research
Published on 27 Sep 2024
Role of disulfidptosis in colorectal adenocarcinoma: implications for prognosis and immunity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1409149
- 248 views
Review
Published on 27 Sep 2024
Biomarkers of lymph node metastasis in esophageal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1457612
- 226 views